News | News By Subject | News by Disease News By Date | Search News

Renal Failure News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
ChemoCentryx, Inc. (CCXI) Dumped By GlaxoSmithKline (GSK) After Phase 2 Data Of CCX168 Is Revealed     12/5/2013
Pfizer Inc. (PFE)'s RAPAMUNE® Doesn't Meet Primary Endpoint in Phase 3B/4 Study     11/11/2013
Alexion Pharmaceuticals Inc. (ALXN)'s Soliris® (eculizumab) Inhibits TMA And Improves Renal Function In AHUS Patients     11/11/2013
Pharmalink AB Snags $15 Million to Undertake Pivotal Studies With Lead Programs in Cancer Therapy and Renal Disease     10/4/2013
AstraZeneca PLC (AZN) Bets $815 Million on FibroGen, Inc.'s Anemia Drug     8/1/2013
Keryx Biopharmaceuticals (KERX) Kidney Drug Meets Late-Stage Trial Goal     1/29/2013
Ikaria Inc.'s LUCASSIN® Approved in Australia     4/24/2012
Affymax, Inc. (AFFY) Receives $10 Million Milestone Payment From Takeda Pharmaceutical Co. Ltd. (TKDG.DE) for FDA Filing of New Drug Application for Hematide(TM)/Peginesatide     8/10/2011
Raptor Pharmaceutical Inc. (RPTP) Cystinosis Drug Meets Late-Stage Trial Goal     7/25/2011
Altus Pharmaceuticals Inc. (ALTU)'s ALTU-237 Achieves Favorable Saftey Profile In Phase 1 Trial     6/3/2008
SGX Pharmaceuticals, Inc. (SGXP) Discontinued Development of SGX523; Announces First Quarter Financial Results     5/13/2008
Keryx Biopharmaceuticals (KERX) Licenses Rights to Japan Tobacco; Torii Pharmaceutical Co. to Pay up to $100 Million     9/26/2007
Amgen (AMGN) Defends Anemia Drugs Before U.S. Panel     9/11/2007

News from Around the Web
Renal Cancer Drug Temsirolimus Shows Promise Against Mesothelioma, Medical University of Vienna Study     5/2/2011
Statins Linked to Better ICU Survival, Swedish Covenant Hospital Study     11/4/2010
No Benefit for Steroids in Allograft Renal Transplant, University of Vienna Study     8/17/2010
Rhesus Factor Controls Renal Function And Male Fertility, UniversitĂ© libre de Bruxelles Study     11/20/2008
Combo Kidney-Pancreas Transplant Boosts Survival In Diabetics; Type 1 Patients Did Better Than Those Having Kidney Replacement Alone, University of Heidelberg Study     5/22/2008
Unique Pattern of Gene Expression Can Indicate Acetaminophen Overdose     11/1/2007
Alternative Kidney Test Reveals Hidden Health Risks     8/15/2006
Drinking Tea May Stave Off Bile Stones And Cancer     7/10/2006
Successful Transplantation From Pig Embryos To Mice     6/20/2006
Feds Warn San Francisco Kaiser Permanente     6/8/2006
Fake Chinese Drug Kills Nine     5/22/2006
Bogus Drugs Kill 4 In Southern China     5/17/2006
Bowel Cleansers Get FDA Warning     5/8/2006
New Research Demonstrates Bone-marrow Derived Stem Cells Can Reverse Genetic Kidney Disease     4/28/2006
Yale University Researchers Identify Gene Depth Protects Against Kidney Stones     3/13/2006

Press Releases
Resverlogix (RVX.TO) Announces Successful Phase 1 Renal Trial Results: Clears Path For Future Phase 2 Studies     11/17/2016
Omeros (OMER) Confirms OMS721 Phase 3 Development Plan With EMA     7/28/2016
Resverlogix (RVX.TO) Announces Dosing Of First Two Patients In Expanded Renal And Orphan Programs     7/22/2016
Ardelyx (ARDX) Reports Progress Of Development Programs     6/22/2016
Omeros Corporation (OMER) Reports First Quarter 2016 Financial Results     5/10/2016
Regulus (RGLS) To Present New RG-101 Data At The International Liver Congress 2016 (ILC 2016)     3/16/2016
Shire (SHPG)'s CINRYZE Receives FDA Fast Track Designation     10/13/2015
ClinMet Metabolomic Panel Shown To Reflect Renal Function Status, May Predict Drug Activity In Diabetic Kidney Disease     11/17/2014
Pharmalink AB Extends Patent Protection For Nefecon® Treatment For Renal Disease     10/27/2014
Efficacy Of Renal Denervation Using Thermal Ablation Technologies Is Dependent On Microanatomy: CBSET To Present Preclinical Evidence At Europcr 2014     5/16/2014
Algorithme Pharma News - Impaired Renal Function Clinical Trials     11/4/2013
Cellceutix (CTIX) Reports in Vivo Tumor Shrinkage in Renal Cancer     1/24/2013
Stealth Peptides Inc. Release: Researchers Present Promising Bendavia Findings at Annual Stealth Peptides Inc. Meeting     11/15/2011
Novartis Pharmaceuticals Corporation (NVS) Phase III Study in Patients Treated With RAD001 One Month After Liver Transplant Shows Similar Efficacy and Better Renal Function     11/9/2011
Medgenics, Inc. Provides Clinical and Regulatory Update     11/9/2011

//-->